What Is Puma Biotechnology Inc (PBYI) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Puma Biotechnology Inc's intrinsic value is estimated at $5.60. Trading at its current price of $8.08, the valuation engine raises significant caution: 10 of 12 models flag downside risk, projecting an average implied return of -30.6%. Model dispersion is worth noting: RCMH-DCF targets $12.59 (+55.8%), versus EPV at $2.06 (-74.5%). This +130.4% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About PBYI?
12 of 13 models are currently active for PBYI. Of these, 1 model suggests upside while 11 models suggest overvaluation. The Bayesian DCF estimates PBYI's intrinsic value at $7.03, implying -13.0% downside from the current price. See which stocks rank higher →
How Does PBYI Rank in Pharmaceutical Preparations?
Among 440 Pharmaceutical Preparations stocks, PBYI ranks #22 by Quality of Company score. CirclFi's QOC score of 8.6/10 evaluates 32 fundamental signals. A score of 8.6 places PBYI in the top tier.
See all Most Undervalued Pharmaceutical Preparations Stocks →
The Pharmaceutical Preparations sector introduces analytical considerations specific to biopharma enterprise businesses. For Puma Biotechnology Inc, metrics like clinical trial success rate provide important context that general-purpose valuation models may underweight.
Is PBYI a Value Trap?
CirclFi's Value Trap algorithm assigns PBYI a score of 26/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Puma Biotechnology Inc. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Puma Biotechnology Inc scores 8.6 out of 10 on our 32-signal quality assessment, a strong rating that demonstrates strong fundamentals across the majority of our quality signals. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +130.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every PBYI valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across PBYI's 12 active models, average confidence is 44%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad